Table 4 Radioimmunotherapy for primary/recurrent SCCHN (no prior RT)
tumor stages | ||
|---|---|---|
T1 | 8 pts | |
T2 | 8 pts | |
T3 | 3 pts | |
T4 | 30 pts | |
N0 | 15 pts | |
N1 | 4 pts | |
N2 | 31 pts | |
N3 | 0 pts | |
primary RT | ||
median dose (Gy) | 66 | [16 - 70,6] |
IMRT | 28 pts | |
3D | 9 pts | |
conventional RT | 9 pts | |
RIT | ||
first treatment | 38/51 pts | |
RIT for disease relapse | 13/51 pts | |
> 1 cycle cetuximab | 48/51 pts | |
response (48 pts) at first follow-up | ||
CR | 10 pts | |
PR | 19 pts | |
SD | 2 pts | |
PD | 5 pts | |
dna | 5 pts | |
f/u unavailable | 7 pts | |